Type 2 Diabetes and
Type 2 Diabetes and prediabetes can be reversed with personalized lifestyle education and support from LifestyleRx and LifeLabs
November 07, 2023 12:00 ET | LifeLabs
Toronto, Ontario, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LifeLabs is pleased to announce its partnership with LifestyleRx to offer Canadians greater support in managing their health with prediabetes and...
Let's Make Time for Diabetes Awareness Month
“We’re never off the clock”: Diabetes Canada launches Let’s Make Time campaign for Diabetes Awareness Month
November 01, 2023 05:30 ET | Diabetes Canada
Toronto, ON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- November is Diabetes Awareness Month and this year, Diabetes Canada is calling on Canadians to show support for people affected by diabetes through the...
TIP_link_300x300.jpg
Wearable Injectors Market Share Worth $13.88 Billion by 2027 - Exclusive Report by The Insight Partners
October 26, 2023 07:18 ET | The Insight Partners
Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Wearable injectors are drug delivery devices that adhere to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and...
AMR Logo.png
Digital Therapeutics Market Is Projected to Gain $22.60 Billion By 2031, Growing at a 19.4% CAGR: Allied Market Research
October 23, 2023 22:00 ET | Allied Market Research
Wilmington, Delaware, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global digital therapeutics market size was estimated at $3.84 billion and is projected to gain $22.60 billion in 2031, exhibiting a...
Emergen logo.png
Global Fc Fusion Protein Market Size to Reach USD 88.68 Billion in 2032 | Emergen Research
October 18, 2023 10:36 ET | Emergen Research
Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Current Market Scenario: The global Fc fusion protein market size reached USD 26.97 Billion in 2020 and is expected to register a significantly...
22157.jpg
US and EUCAN Digital Marketing Metrics and Trends in Type 2 Diabetes, 2023 Study - Novo Nordisk's Ozempic.com Achieved the Highest Total Traffic Across T2D Patient Brand Sites in the US
October 18, 2023 03:58 ET | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Type 2 Diabetes" report has been added to ResearchAndMarkets.com's offering. This report assesses key digital marketing...
The Alpine Center CCPHP
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Medicine Program
October 16, 2023 11:00 ET | Castle Connolly Private Health Partners
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Program
22157.jpg
Global Diabetes Diagnostics Market Research Report 2023-2030 - High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
October 09, 2023 03:28 ET | Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Diabetes Diagnostics Market...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
September 29, 2023 07:32 ET | Structure Therapeutics Inc.
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with existing cash, cash equivalents...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
September 29, 2023 07:30 ET | Structure Therapeutics Inc.
GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight loss at 28 days supporting once-daily...